vs

Side-by-side financial comparison of Axsome Therapeutics, Inc. (AXSM) and RADIANT LOGISTICS, INC (RLGT). Click either name above to swap in a different company.

RADIANT LOGISTICS, INC is the larger business by last-quarter revenue ($232.1M vs $196.0M, roughly 1.2× Axsome Therapeutics, Inc.). RADIANT LOGISTICS, INC runs the higher net margin — 2.3% vs -14.6%, a 16.9% gap on every dollar of revenue. On growth, Axsome Therapeutics, Inc. posted the faster year-over-year revenue change (65.0% vs -12.3%). RADIANT LOGISTICS, INC produced more free cash flow last quarter ($11.6M vs $-18.7M). Over the past eight quarters, Axsome Therapeutics, Inc.'s revenue compounded faster (61.7% CAGR vs 12.1%).

Jazz Pharmaceuticals plc is a global biopharmaceutical company with a focus on oncology and neuroscience. It was founded in 2003 in California, United States and is now headquartered in Dublin, Ireland.

Radiant Logistics, Inc. is a leading third-party logistics provider offering end-to-end supply chain solutions, domestic and international freight forwarding, warehousing, and last-mile delivery services. It primarily serves North American markets, with key client segments including retail, manufacturing, e-commerce, and industrial sectors, helping businesses optimize logistics workflows and cut operational costs.

AXSM vs RLGT — Head-to-Head

Bigger by revenue
RLGT
RLGT
1.2× larger
RLGT
$232.1M
$196.0M
AXSM
Growing faster (revenue YoY)
AXSM
AXSM
+77.3% gap
AXSM
65.0%
-12.3%
RLGT
Higher net margin
RLGT
RLGT
16.9% more per $
RLGT
2.3%
-14.6%
AXSM
More free cash flow
RLGT
RLGT
$30.4M more FCF
RLGT
$11.6M
$-18.7M
AXSM
Faster 2-yr revenue CAGR
AXSM
AXSM
Annualised
AXSM
61.7%
12.1%
RLGT

Income Statement — Q4 FY2025 vs Q2 FY2026

Metric
AXSM
AXSM
RLGT
RLGT
Revenue
$196.0M
$232.1M
Net Profit
$-28.6M
$5.3M
Gross Margin
Operating Margin
-13.8%
3.2%
Net Margin
-14.6%
2.3%
Revenue YoY
65.0%
-12.3%
Net Profit YoY
61.9%
-18.0%
EPS (diluted)
$-0.55
$0.11

Green = leading value per metric. Periods may differ when fiscal calendars don't align.

8-Quarter Revenue & Profit Trend

Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.

Revenue
AXSM
AXSM
RLGT
RLGT
Q4 25
$196.0M
$232.1M
Q3 25
$171.0M
$226.7M
Q2 25
$150.0M
$220.6M
Q1 25
$121.5M
$214.0M
Q4 24
$118.8M
$264.5M
Q3 24
$104.8M
$203.6M
Q2 24
$87.2M
$206.0M
Q1 24
$75.0M
$184.6M
Net Profit
AXSM
AXSM
RLGT
RLGT
Q4 25
$-28.6M
$5.3M
Q3 25
$-47.2M
$1.3M
Q2 25
$-48.0M
$4.9M
Q1 25
$-59.4M
$2.5M
Q4 24
$-74.9M
$6.5M
Q3 24
$-64.6M
$3.4M
Q2 24
$-79.3M
$4.8M
Q1 24
$-68.4M
$-703.0K
Operating Margin
AXSM
AXSM
RLGT
RLGT
Q4 25
-13.8%
3.2%
Q3 25
-27.0%
0.9%
Q2 25
-24.5%
2.4%
Q1 25
-46.9%
1.6%
Q4 24
-61.1%
3.3%
Q3 24
-59.8%
1.9%
Q2 24
-89.5%
2.4%
Q1 24
-89.7%
-0.5%
Net Margin
AXSM
AXSM
RLGT
RLGT
Q4 25
-14.6%
2.3%
Q3 25
-27.6%
0.6%
Q2 25
-32.0%
2.2%
Q1 25
-48.9%
1.2%
Q4 24
-63.1%
2.4%
Q3 24
-61.7%
1.7%
Q2 24
-91.0%
2.3%
Q1 24
-91.1%
-0.4%
EPS (diluted)
AXSM
AXSM
RLGT
RLGT
Q4 25
$-0.55
$0.11
Q3 25
$-0.94
$0.03
Q2 25
$-0.97
$0.10
Q1 25
$-1.22
$0.05
Q4 24
$-1.54
$0.13
Q3 24
$-1.34
$0.07
Q2 24
$-1.67
$0.11
Q1 24
$-1.44
$-0.02

Balance Sheet & Financial Strength

Snapshot of each company's liquidity, leverage and book value from the latest quarter.

Metric
AXSM
AXSM
RLGT
RLGT
Cash + ST InvestmentsLiquidity on hand
$322.9M
$31.9M
Total DebtLower is stronger
Stockholders' EquityBook value
$88.3M
$229.8M
Total Assets
$689.8M
$439.4M
Debt / EquityLower = less leverage

8-quarter trend — quarters aligned by calendar period.

Cash + ST Investments
AXSM
AXSM
RLGT
RLGT
Q4 25
$322.9M
$31.9M
Q3 25
$325.3M
$28.1M
Q2 25
$303.0M
$22.9M
Q1 25
$300.9M
$19.0M
Q4 24
$315.4M
$19.9M
Q3 24
$327.3M
$10.4M
Q2 24
$315.7M
$24.9M
Q1 24
$331.4M
$31.2M
Stockholders' Equity
AXSM
AXSM
RLGT
RLGT
Q4 25
$88.3M
$229.8M
Q3 25
$73.7M
$225.7M
Q2 25
$73.1M
$226.0M
Q1 25
$53.2M
$218.2M
Q4 24
$57.0M
$214.4M
Q3 24
$92.9M
$212.4M
Q2 24
$102.9M
$209.4M
Q1 24
$144.0M
$206.0M
Total Assets
AXSM
AXSM
RLGT
RLGT
Q4 25
$689.8M
$439.4M
Q3 25
$669.3M
$445.3M
Q2 25
$639.8M
$426.8M
Q1 25
$596.7M
$414.5M
Q4 24
$568.5M
$386.8M
Q3 24
$561.5M
$375.3M
Q2 24
$548.2M
$371.2M
Q1 24
$545.7M
$364.0M

Cash Flow & Capital Efficiency

How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.

Metric
AXSM
AXSM
RLGT
RLGT
Operating Cash FlowLast quarter
$-18.7M
$12.4M
Free Cash FlowOCF − Capex
$-18.7M
$11.6M
FCF MarginFCF / Revenue
-9.6%
5.0%
Capex IntensityCapex / Revenue
0.0%
0.3%
Cash ConversionOCF / Net Profit
2.33×
TTM Free Cash FlowTrailing 4 quarters
$-93.9M
$8.5M

8-quarter trend — quarters aligned by calendar period.

Operating Cash Flow
AXSM
AXSM
RLGT
RLGT
Q4 25
$-18.7M
$12.4M
Q3 25
$1.0M
$2.5M
Q2 25
$-32.4M
$3.1M
Q1 25
$-43.4M
$-5.7M
Q4 24
$-26.2M
$15.7M
Q3 24
$-18.6M
$205.0K
Q2 24
$-30.1M
$1.3M
Q1 24
$-53.5M
$3.9M
Free Cash Flow
AXSM
AXSM
RLGT
RLGT
Q4 25
$-18.7M
$11.6M
Q3 25
$988.0K
$977.0K
Q2 25
$-32.4M
$2.2M
Q1 25
$-43.7M
$-6.4M
Q4 24
$-26.2M
$14.1M
Q3 24
$-18.7M
$-1.9M
Q2 24
$-30.2M
$-185.0K
Q1 24
$-53.6M
$1.8M
FCF Margin
AXSM
AXSM
RLGT
RLGT
Q4 25
-9.6%
5.0%
Q3 25
0.6%
0.4%
Q2 25
-21.6%
1.0%
Q1 25
-36.0%
-3.0%
Q4 24
-22.1%
5.3%
Q3 24
-17.9%
-0.9%
Q2 24
-34.6%
-0.1%
Q1 24
-71.4%
1.0%
Capex Intensity
AXSM
AXSM
RLGT
RLGT
Q4 25
0.0%
0.3%
Q3 25
0.0%
0.7%
Q2 25
0.0%
0.4%
Q1 25
0.3%
0.3%
Q4 24
0.0%
0.6%
Q3 24
0.1%
1.0%
Q2 24
0.1%
0.7%
Q1 24
0.1%
1.2%
Cash Conversion
AXSM
AXSM
RLGT
RLGT
Q4 25
2.33×
Q3 25
1.90×
Q2 25
0.63×
Q1 25
-2.26×
Q4 24
2.43×
Q3 24
0.06×
Q2 24
0.26×
Q1 24

Financial Flow Comparison

Revenue → gross profit → operating profit → net profit for each company.

Revenue Breakdown by Segment

AXSM
AXSM

Segment breakdown not available.

RLGT
RLGT

Transferred Over Time$201.2M87%
Other$25.0M11%
Value Added Services$4.2M2%
Transferred At Point In Time$1.8M1%

Related Comparisons